Scarica l'app Stockscreener
4.66
1.97%
0.09
Dopo l'orario di chiusura:
4.72
0.06
+1.29%
Precedente Chiudi:
$4.57
Aprire:
$4.19
Volume 24 ore:
604.23K
Relative Volume:
2.75
Capitalizzazione di mercato:
$87.15M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+30.90%
1M Prestazione:
+80.62%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.15
$5.00
Intervallo di 1 settimana:
$3.56
$7.26
Portata 52W:
$2.14
$12.50
Kalaris Therapeutics Inc Stock (KLRS) Company Profile
Nome
Kalaris Therapeutics Inc
Settore
Industria
Telefono
650-249-2727
Indirizzo
628 MIDDLEFIELD ROAD, PALO ALTO
Confronta KLRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KLRS
Kalaris Therapeutics Inc
|
4.66 | 74.81M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Kalaris Therapeutics Inc Stock (KLRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-23 | Ripresa | Piper Sandler | Neutral |
| 2025-05-07 | Iniziato | Leerink Partners | Outperform |
| 2025-04-08 | Iniziato | William Blair | Outperform |
Kalaris Therapeutics Inc Borsa (KLRS) Ultime notizie
Momentum divergence signals in Kalaris Therapeutics Inc. chart2025 Key Highlights & High Return Stock Watch Alerts - Newser
Using data models to predict Kalaris Therapeutics Inc. stock movementPortfolio Profit Report & Weekly Top Performers Watchlists - Newser
Kalaris (KLRS.O) Surges 13%—What's Driving the Intraday Move? - AInvest
Kalaris Therapeutics Peeks Ahead: Strong Cash Reserves Empower Vital Trials - StocksToTrade
Kalaris Therapeutics shares surge 32.38% intraday after Zacks and Raymond James upgrade ratings and merger completion. - AInvest
Kalaris Therapeutics, Inc.Common Stock (Nasdaq:KLRS) Stock Quote - FinancialContent
What data driven models say about Kalaris Therapeutics Inc.’s futureQuarterly Trade Summary & AI Powered Market Entry Ideas - Newser
Is Kalaris Therapeutics Inc. stock reversal real or fake2025 Year in Review & Smart Money Movement Tracker - Newser
Chart overlay techniques for tracking Kalaris Therapeutics Inc.2025 Institutional Moves & Weekly Watchlist for Consistent Profits - Newser
Raymond James Initiates Kalaris Therapeutics at Strong Buy - MarketScreener
Can a trend reversal in Kalaris Therapeutics Inc. lead to recoveryJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - Newser
Does Kalaris Therapeutics Inc. fit your quant trading modelIndex Update & Weekly Breakout Stock Alerts - Newser
Kalaris Therapeutics Inc. stock trend outlook and recovery pathWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Volatility clustering patterns for Kalaris Therapeutics Inc.2025 Trading Recap & Real-Time Chart Breakout Alerts - Newser
Top chart patterns to watch in Kalaris Therapeutics Inc.2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Using Bollinger Bands to evaluate Kalaris Therapeutics Inc.Portfolio Risk Summary & Breakout Confirmation Alerts - Newser
Can Kalaris Therapeutics Inc. stock outperform in a bear marketWeekly Risk Summary & Smart Allocation Stock Tips - khodrobank.com
Key metrics from Kalaris Therapeutics Inc.’s quarterly dataEarnings Beat & High Accuracy Swing Entry Alerts - Newser
Recap Report: Is Kalaris Therapeutics Inc. stock risky to hold nowJuly 2025 Summary & AI Powered Market Entry Strategies - khodrobank.com
How sensitive is Kalaris Therapeutics Inc. to inflationWeekly Market Outlook & Free Community Consensus Stock Picks - khodrobank.com
Analyzing Kalaris Therapeutics Inc. with multi timeframe chartsIndex Update & Accurate Entry/Exit Alerts - Newser
Forecasting Kalaris Therapeutics Inc. price range with options dataJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - Newser
Is Kalaris Therapeutics Inc. impacted by rising ratesQuarterly Growth Report & Fast Entry High Yield Stock Tips - khodrobank.com
Kalaris Therapeutics Inc. recovery potential after sell offJuly 2025 Catalysts & Verified Momentum Stock Ideas - Newser
What earnings revisions data tells us about Kalaris Therapeutics Inc.2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Why is Kalaris Therapeutics Inc. stock going upJuly 2025 Levels & Daily Momentum Trading Reports - khodrobank.com
Kalaris Therapeutics Inc. (KLRS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Kalaris Therapeutics Inc. Matches Institutional Buying FilterWeekly Profit Summary & Stepwise Swing Trade Plans - beatles.ru
What MACD signals say about Kalaris Therapeutics Inc.Layoff News & Risk Controlled Stock Pick Alerts - Newser
Will Kalaris Therapeutics Inc. stock go up soon2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
What’s the recovery path for long term holders of Kalaris Therapeutics Inc.Trade Analysis Summary & Safe Capital Growth Tips - Newser
Order Flow Trends Show Accumulation in Kalaris Therapeutics Inc.Weekly Stock Recap & Risk Controlled Daily Trade Plans - beatles.ru
Will Kalaris Therapeutics Inc. continue its uptrendJuly 2025 Market Mood & Accurate Intraday Trade Tips - Newser
Using AI based signals to follow Kalaris Therapeutics Inc.Market Sentiment Summary & Breakout Confirmation Trade Signals - Newser
Risk vs reward if holding onto Kalaris Therapeutics Inc.July 2025 Intraday Action & Daily Entry Point Alerts - Newser
Developing predictive dashboards with Kalaris Therapeutics Inc. data - Newser
What recovery options are there for Kalaris Therapeutics Inc.2025 Technical Overview & Daily Stock Trend Watchlist - Newser
Using data filters to optimize entry into Kalaris Therapeutics Inc.Quarterly Portfolio Report & Advanced Swing Trade Entry Plans - Newser
Will Kalaris Therapeutics Inc. bounce back from current support2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - Newser
Will Heron Therapeutics Inc. continue its uptrend2025 Short Interest & Community Consensus Picks - Newser
Kalaris Therapeutics Inc Azioni (KLRS) Dati Finanziari
Non sono disponibili dati finanziari per Kalaris Therapeutics Inc (KLRS). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):